- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
New breast cancer Web site launched
Patients and professionals who want more information on breast cancer have a new resource on the Internet's World Wide Web.
Patients and professionals who want more information on breast cancer have a new resource on the Internet's World Wide Web.
At the end of last year, President Clinton launched the National Action Plan on Breast Cancer Web site.
The Web site, coordinated by the Department of Health and Human Services' Office on Women's Health, serves as a gateway to information on breast cancer research, treatment and prevention.
Some of the resources on the Web site include answers to frequently asked questions about breast cancer, as well as information on clinical trials and research, educational conferences, advocacy groups, publications, and government and private resources. Users can also initiate a search on the Web site to locate specific information on breast cancer.
The Web site is available in both English and Spanish on the Internet at http://www.napbc.org. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
